Table 1 Sociodemographic characteristics and chronic disease distribution among participants
Variable | Category | Naturally infected group | Vaccinated group |
|---|---|---|---|
n (%) (n = 355) | n (%) (n = 355) | ||
Sex | Male | 154 (43.4) | 154 (43.4) |
| Â | Female | 201 (56.6) | 201 (56.6) |
Age | 18–29 | 66 (18.6) | 66 (18.6) |
|  | 30–39 | 82 (23.1) | 82 (23.1) |
|  | 40–49 | 107 (30.1) | 107 (30.1) |
|  | 50–59 | 58 (16.3) | 58 (16.3) |
|  | 60–69 | 38 (8.7) | 38 (8.7) |
|  | > 70 | 11 (3.1) | 11 (3.1) |
Presence of previous SARS-CoV-2 infection | Yes | 355 (100) | Â |
| Â | No* | - | 355 (100) |
Severity of infection | Mild | 166 (46.8) | - |
| Â | Moderate | 174 (49) | - |
| Â | Severe | 15 (4.2) | - |
Vaccination status | Vaccinated | - | 355 (100) |
| Â | Not Vaccinated | 355 (100) | - |
Vaccine dose taken | First dose | - | 154 (43.4) |
| Â | Second dose | - | 131 (36.9) |
| Â | Third dose | - | 70 (19.7) |
Duration since vaccination | ≤ 3 months | - | 48 (13.5) |
|  | 3–6 months | - | 64 (18) |
|  | 6–9 months | - | 66 (18.6) |
|  | 9–12 months | - | 28 (7.9) |
|  | > 12 months | - | 149 (42) |
Hypertension | Present | 52 (14.6) | 64 (18) |
Absent | 303 (85.4) | 291 (82) | |
Diabetes | Present | 49 (13.8) | 54 (15.2) |
Absent | 306 (86.2) | 301 (84.8) | |
Asthma | Present | 12 (3.4) | 6 (1.7) |
Absent | 343 (96.6) | 349 (98.3) | |
Kidney disease | Present | 14 (3.9) | 20 (5.6) |
Absent | 341 (96.1) | 335 (94.4) | |
Liver disease | Present | 9 (2.5) | 15 (4.2) |
Absent | 346 (97.5) | 340 (95.8) | |
Thyroid disease | Present | 17 (4.8) | 21 (5.9) |
Absent | 338 (95.2) | 334 (94.1) |